source
- Roche turns to Dualitas to find new bispecific approaches for immunologyRoche is turning up the heat on its hunt for next-generation bispecific antibodies in a deal that will involve screening 300,000 new combinations for inflammatory and immunology conditions. The Swi…Endpoints · 1mo ago↗ source
- Novo signs $1.4 billion deal with Orbis Medicines to develop oral macrocycle cardiometabolic drugsNovo, which recently rebranded from Novo Nordisk, announced a partnership with Copenhagen‑based Orbis Medicines. The agreement could provide up to $1.4 billion in upfront payments and milestone pay…